Skip to main content
C

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 TW Manufacturing
Filings indexed 393 across all filing types
Latest filing 2026-03-05 Regulatory Filings
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議發行限制員工權利新股
Regulatory Filings
2026-03-05 Chinese
公告本公司董事會決議不繼續辦理 114年股東常會通過之私募有價證券案
Regulatory Filings
2026-03-05 Chinese
本公司召開115年股東常會相關事宜。
Regulatory Filings
2026-03-05 Chinese
115年02月董事會成員及持股
Regulatory Filings
2026-03-05 Chinese
115年02月內部人持股異動(事後)
Regulatory Filings
2026-03-05 Chinese
代子公司「中國化學製藥股份有限公司」公告 其董事會通過員工酬勞及董監事酬勞分派議案
Regulatory Filings
2026-03-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.